Literature DB >> 17634711

Bromocriptine-responsive Cushing's disease; clinical and biochemical remission accompanied by amelioration of impaired ocular movement.

Mitsunobu Kawamura1, Tae Nakano, Hiroko Miki, Yuriko Tamura, Shigeru Miyazaki, Yukio Hirata.   

Abstract

A 73-year-old woman presented with disturbance of right eyelid opening with ptosis and impairment of right ocular movement, and later was found to have Cushingoid features. Endocrine examinations revealed that plasma ACTH and cortisol levels were elevated, lack of circadian rhythm, resistant to low-doses (0.5, 1, 2 mg) and high-dose (8 mg) dexamethasone, and responsive to CRH and DDAVP. Magnetic resonance imaging (MRI) revealed a large pituitary tumor invading the right cavernous sinus. After two months treated with bromocriptine (5 mg/day), she showed clinical improvement with normalization of plasma ACTH and cortisol levels, and improvement of right eyelid opening and ocular movement. MRI, however, revealed no apparent reduction in the size of pituitary tumor. This is a rare case of bromocriptine-responsive Cushing's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634711     DOI: 10.2169/internalmedicine.46.6436

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  1 in total

1.  Transcriptional control of adrenal steroidogenesis: novel connection between Janus kinase (JAK) 2 protein and protein kinase A (PKA) through stabilization of cAMP response element-binding protein (CREB) transcription factor.

Authors:  Anne-Marie Lefrancois-Martinez; Antonine Blondet-Trichard; Nadine Binart; Pierre Val; Céline Chambon; Isabelle Sahut-Barnola; Jean-Christophe Pointud; Antoine Martinez
Journal:  J Biol Chem       Date:  2011-08-01       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.